It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even simple tasks like walking or sitting comfortably. If traditional treatments ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.